Article citationsMore>>

McComsey, G.A., Kitch, D., Daar, E.S., Tierney, C., Jahed, N.C., Melbourne, K., Ha, B., Brown, T.T., Bloom, A., Fedarko, N. and Sax, P.E. (2012) Inflammation Markers after Randomization to Abacavir/Lamivudine or Tenofovir/Emtricitabine with Efavirenz or Atazanavir/Ritonavir. AIDS, 26, 1371-1385.
http://dx.doi.org/10.1097/QAD.0b013e328354f4fb

has been cited by the following article:

• TITLE: Assessment of Renal Function among HIV-Infected Patients on Combination Antiretroviral Therapy at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

  AUTHORS: Kassahun Eneyew, Daniel Seifu, Wondwossen Amogne, M. K. C. Menon

  KEYWORDS: Renal Dysfunction, HAART, HIV-Infected Patients, eGFR, Creatinine Clearence, HIVAN

  JOURNAL NAME: Technology and Investment, Vol.7 No.3, August 19, 2016

  ABSTRACT: Background: Acquired immunodeficiency syndrome (AIDS) is a spectrum of disease states characterized by progressive immunosuppression. Sub-Saharan Africa is heavily affected by human immunodeficiency virus (HIV) and AIDS than any other region of the world. Renal complications are important component of advanced HIV disease, and these complications significantly contribute to morbidity and mortality in HIV/AIDS patients. Aim of the Study: To assess renal function abnormalities in HIV infected patients and compare with treatment-naive and HIV-negative control groups. Methods: A retrospective cross sectional study of comparative nature was designed and samples and biochemical data were collected from July 1/2012 to February 1/2013 in patients attending the ART clinic at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Renal functions of 180 participants were assessed. The data obtained were analyzed using SPSS version 16.0. Result: A total of 180 participants grouped as HIV-negative controls (n = 60), HIV+ treatment-naive (n = 60) and HIV+ on HAART were recruited to participate in this study. Out of 180 participants included in the study, 59 (32.78%) were males and the remaining 121 (67.22%) were females. Mean serum total protein was higher in patients on HAART groups (5.78 ± 1.39) than treatment-naive (4.76 ± 2.19). There was significant reduction (p 2) is higher in treatment-naive participants than those on HAART and HIV-negative control groups.